Philippa Fibert
Overview
Explore the profile of Philippa Fibert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lawrence K, Fibert P, Hobbs J, Myrissa K, Toribio-Mateas M, Quadt F, et al.
BMJ Open
. 2023 Dec;
13(12):e071063.
PMID: 38149413
Introduction: Current interventions for children with attention-deficit/hyperactivity disorder (ADHD) are primarily medication, behavioural therapy and parent training. However, research suggests dietary manipulations may provide therapeutic benefit for some. There is...
2.
Gaertner K, von Ammon K, Fibert P, Frass M, Frei-Erb M, Klein-Laansma C, et al.
Complement Ther Med
. 2023 Jul;
76:102961.
PMID: 37393961
Background: Randomised controlled trials (RCTs) are an established research method to investigate the effects of an intervention. Several recent systematic reviews and meta-analyses of RCTs with homeopathic interventions have identified...
3.
Weiermayer P, Frass M, Fibert P, Klein-Laansma C, Ulbrich-Zurni S
Homeopathy
. 2023 Mar;
112(4):226-239.
PMID: 36929496
Background: Clinical observational studies are an important methodological approach in human and veterinary research, examining and describing treatment experience with good external validity. There are currently few observational studies in...
4.
Miglani A, Manchanda R, Kalsi A, Kaur P, Saini B, Arora A, et al.
Homeopathy
. 2022 Aug;
112(1):22-29.
PMID: 35988581
Background: Most of the symptoms of coronavirus disease 2019 (COVID-19) are covered by large repertory rubrics and hence many remedies have been proposed as "genus epidemicus". The aim of this...
5.
Takacs M, Frass M, Walder G, Fibert P, Rottensteiner M, Gluck W, et al.
Complement Ther Clin Pract
. 2021 May;
44:101415.
PMID: 33989861
Background: and purpose. COVID-19 is a novel viral disease causing worldwide pandemia. The aim of this study was to describe the effect of adjunctive individualized homeopathic treatment delivered to hospitalized...
6.
Fibert P, Relton C
BMJ Paediatr Open
. 2020 Dec;
4(1):e000771.
PMID: 33294627
Objective: To identify interventions being used to manage attention-deficit/hyperactivity disorder (ADHD) in the UK. Design: A survey within the Sheffield Treatments for ADHD Research project. A convenience sample of participants...
7.
Fibert P, Peasgood T, Relton C
Eur J Pediatr
. 2019 Apr;
178(7):983-993.
PMID: 31020392
Attention deficit hyperactivity disorder (ADHD) is a lifelong condition associated with considerable costs. The long-term effectiveness and acceptability of treatments to improve outcomes remains in doubt. Long-term trials are needed...
8.
Fibert P, Relton C, Peasgood T, Daley D
Pilot Feasibility Stud
. 2018 Mar;
4:61.
PMID: 29511570
Background: Attention deficit hyperactivity disorder (ADHD) is a common and growing problem and a leading cause of child referrals to Child and Adult Mental Health Services (CAMHS). It is a...
9.
Relton C, Cooper K, Viksveen P, Fibert P, Thomas K
Homeopathy
. 2017 May;
106(2):69-78.
PMID: 28552176
Aim: To systematically review surveys of 12-month prevalence of homeopathy use by the general population worldwide. Methods: Studies were identified via database searches to October 2015. Study quality was assessed...
10.
Fibert P, Relton C, Heirs M, Bowden D
Homeopathy
. 2016 May;
105(2):194-201.
PMID: 27211327
Cprs-r: L) every 4 months, from which DSMIV total scores were extracted; and Measure Your Own Medical Outcome Profile (MYMOP) every consultation. An interaction between time (baseline/4 months) and group...